# TransCode Therapeutics, Inc. (RNAZ)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RNAZ/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -24.49M | $ -4.98B | $ 652.4K | $ 138.36M |
| 2025 | $ 0 | $ -35.49M | $ -19.99M | $ 0 | $ 10.34M |
| 2024 | $ 0 | $ -17.61M | $ -14.04M | $ 38.3K | $ -2.02M |
| 2023 | $ 0 | $ -20.05M | $ -19.58M | $ 450.6K | $ 1.64M |
| 2022 | $ 0 | $ -19.62M | $ -17.72M | $ 0 | $ 3.24M |
| 2021 | $ 0 | $ -8.13M | $ -7.59M | $ 0 | $ 20.40M |
| 2020 | $ 0 | $ -2.99M | $ -628.0K | $ 2.09M | $ -3.41M |
| 2019 | $ 0 | $ -252.5K | $ 0 | $ 927.8K | $ -1.10M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.09 |
| Current Ratio | 1.97 |

## Other views

- [Metrics](https://sponda.capital/en/RNAZ.md)
- [Charts](https://sponda.capital/en/RNAZ/charts.md)
- [Compare](https://sponda.capital/en/RNAZ/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.